Atria Investments Inc Increases Stock Position in CME Group Inc. $CME

Atria Investments Inc grew its position in shares of CME Group Inc. (NASDAQ:CME) by 10.2% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 30,768 shares of the financial services provider’s stock after purchasing an additional 2,845 shares during the period. Atria Investments Inc’s holdings in CME Group were worth $8,313,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in CME. Empowered Funds LLC increased its holdings in CME Group by 11.5% in the first quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock valued at $2,660,000 after buying an additional 1,037 shares during the last quarter. RFG Advisory LLC purchased a new position in CME Group in the 2nd quarter valued at $716,000. Bayforest Capital Ltd purchased a new position in CME Group during the 2nd quarter worth $114,000. Ritholtz Wealth Management lifted its position in CME Group by 22.6% in the second quarter. Ritholtz Wealth Management now owns 5,455 shares of the financial services provider’s stock valued at $1,503,000 after purchasing an additional 1,004 shares during the period. Finally, Generali Asset Management SPA SGR grew its holdings in CME Group by 91.7% during the second quarter. Generali Asset Management SPA SGR now owns 7,550 shares of the financial services provider’s stock worth $2,081,000 after acquiring an additional 3,612 shares during the period. 87.75% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at CME Group

In other news, Director William R. Shepard purchased 251 shares of the stock in a transaction that occurred on Tuesday, December 30th. The stock was acquired at an average price of $278.37 per share, with a total value of $69,870.87. Following the purchase, the director owned 258,710 shares in the company, valued at $72,017,102.70. This represents a 0.10% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Terrence A. Duffy sold 25,000 shares of the stock in a transaction on Thursday, December 11th. The stock was sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the transaction, the chief executive officer owned 65,804 shares in the company, valued at approximately $17,737,468.20. This trade represents a 27.53% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.30% of the stock is currently owned by insiders.

CME Group Price Performance

Shares of NASDAQ CME opened at $303.07 on Friday. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.03 and a quick ratio of 1.02. The business’s fifty day moving average price is $279.82 and its two-hundred day moving average price is $274.00. The firm has a market capitalization of $109.29 billion, a PE ratio of 27.16, a P/E/G ratio of 3.28 and a beta of 0.27. CME Group Inc. has a 1-year low of $244.43 and a 1-year high of $309.35.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, February 4th. The financial services provider reported $2.77 EPS for the quarter, beating analysts’ consensus estimates of $2.75 by $0.02. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The company had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same period last year, the company earned $2.52 earnings per share. The company’s quarterly revenue was up 8.1% compared to the same quarter last year. On average, research analysts expect that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, March 26th. Investors of record on Tuesday, March 10th will be issued a dividend of $1.30 per share. This is an increase from CME Group’s previous quarterly dividend of $1.25. This represents a $5.20 annualized dividend and a dividend yield of 1.7%. The ex-dividend date is Tuesday, March 10th. CME Group’s dividend payout ratio is 44.80%.

Wall Street Analysts Forecast Growth

CME has been the topic of a number of research analyst reports. UBS Group reiterated a “neutral” rating and set a $310.00 target price on shares of CME Group in a research report on Friday, February 6th. JPMorgan Chase & Co. increased their price objective on shares of CME Group from $262.00 to $266.00 and gave the stock an “underweight” rating in a report on Thursday, February 5th. Piper Sandler upped their price objective on CME Group from $296.00 to $313.00 and gave the stock an “overweight” rating in a report on Thursday, November 13th. Jefferies Financial Group reduced their target price on CME Group from $304.00 to $302.00 and set a “buy” rating on the stock in a report on Monday, January 12th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on shares of CME Group from $312.00 to $316.00 and gave the company a “buy” rating in a research report on Thursday, February 5th. Nine investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $299.53.

More CME Group News

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME raised shareholder payouts — the board declared a Q1 quarterly dividend of $1.30 (up from $1.25) and an annual variable dividend of $6.15 based on 2025 results (total ≈ $2.2B), both payable March 26; that boosts cash return to investors. CME Group Declares Annual Variable Dividend and Q1 2026 Quarterly Dividend
• Positive Sentiment: Analyst price-target lift — Rothschild & Co Redburn raised its CME price target to $333 from $300 (still a “neutral” rating), implying roughly 9.7% upside versus recent levels, which can support buying interest. Rothschild & Co Redburn Adjusts Price Target on CME Group to $333 From $300, Maintains Neutral Rating
• Positive Sentiment: New product rollout and execution — CME reported first trades in new Cardano, Chainlink and Stellar crypto futures and is actively exploring a rare-earths futures contract; these product additions expand fee pools and diversify revenue. CME Group Announces First Trades for New Cardano, Chainlink and Stellar Cryptocurrency Futures CME Weighs Launching First-Ever Rare Earth Futures Contract / Reuters
• Positive Sentiment: Asia expansion — reports say CME plans to list Taiwan and Hong Kong warehouses for aluminium futures in Asia, a move that could deepen regional market presence and increase volumes. Exclusive: CME to list Taiwan, Hong Kong warehouses in Asia aluminium push, sources say
• Neutral Sentiment: CFTC advisory involvement — the CFTC formed an Innovation Advisory Committee that includes a CME executive; this provides regulatory engagement but unclear near-term financial impact. CFTC Forms Innovation Advisory Committee With 35 Crypto and Finance Industry Leaders
• Neutral Sentiment: Board slate announced — CME named director nominees for the annual meeting; routine governance news that is unlikely to move the stock materially. CME Group Inc. Names Slate of Director Nominees
• Neutral Sentiment: Analyst/earnings commentary — recent analyst-question coverage from the Q4 call provides context for growth drivers but contains no new guidance. 5 Must-Read Analyst Questions From CME Group’s Q4 Earnings Call
• Negative Sentiment: Short-interest reporting is inconsistent — filings flagged a “significant increase” in February short interest but published data show zeros/NaN, creating ambiguity; if short interest is actually rising, that could add downward pressure.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.